Please note: a valid prescription is required for all prescription medication.
Mayzent® Tablets for Multiple Sclerosis
Stock up and Save - Get 20% off when you buy 3 or more of any one product. Use code SAVE20 at checkout.
Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.
$4,094.99
Secure Encrypted Payments
Mayzent is a prescription tablet used in adults with relapsing forms of multiple sclerosis. It helps reduce relapse activity by targeting immune pathways in the central nervous system. This page explains how it works, who it may suit, and how to order with US delivery from Canada, including options if paying without insurance.
What Mayzent Is and How It Works
Novartis Mayzent contains siponimod, a selective sphingosine 1‑phosphate (S1P) receptor modulator. It helps keep certain white blood cells from leaving lymph nodes, which may reduce inflammation in the brain and spinal cord. The treatment is taken by mouth once daily after a short start-up schedule. Effects can include slower relapse activity and fewer new MRI lesions, as described in the official labeling.
YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing.
Before the first dose, CYP2C9 genotype testing is required on the label. People with CYP2C9*3/*3 should not use this medicine. Your prescriber will consider cardiac history, infection risks, eye health, and current therapies before starting.
Who It’s For
This medicine is indicated for adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Some patients with specific heart rhythm problems, recent cardiovascular events, or certain liver issues should avoid it. Mayzent for MS is not studied in children.
People without varicella-zoster immunity may need vaccination before starting. Those who are pregnant or planning pregnancy should discuss safer options. For a broader overview of the condition and therapies, see our category page on Multiple Sclerosis.
Dosage and Usage
The label uses a once-daily schedule after a brief titration phase. The exact schedule depends on genotype and cardiac status. Mayzent dosing typically begins with a starter pack that gradually increases to a maintenance amount. Swallow tablets whole with water, with or without food, at the same time each day.
Key setup steps on the label may include CYP2C9 testing, checking blood pressure, baseline eye exam for those at risk of macular edema, and confirming varicella immunity. People with certain preexisting heart conditions may require first-dose monitoring. Avoid live vaccines during treatment and for the recommended period after stopping.
If the medicine is interrupted for several days early in therapy, the label may require restarting the titration; your healthcare professional will advise. Always follow your prescriber’s directions and the official patient information.
Strengths and Forms
This therapy is supplied as film‑coated siponimod tablets. Commonly published strengths include 0.25 mg, 0.5 mg, 1 mg, and 2 mg, with a starter pack used to reach the prescribed maintenance amount. Availability may vary by market and package size.
Missed Dose and Timing
Take a missed dose as soon as remembered the same day, then resume your usual time the next day. Do not double up. If several consecutive doses are missed, the label may recommend re‑titration. When unsure about a siponimod dose after an interruption, consult the official information and your prescriber before restarting. Consistency helps maintain steady levels, so set reminders and keep doses at a regular time.
Storage and Travel Basics
Store tablets at room temperature in the original blister pack to protect from moisture. Keep out of reach of children and pets. When traveling, carry your prescription in your hand luggage with a copy of the label information. Use a pill organizer only for the week if it preserves dryness, and keep a list of your medicines with emergency contact details. Avoid excess heat, freezing, and direct sunlight.
Benefits
This class can reduce relapse frequency and new MRI lesion formation in relapsing multiple sclerosis. Once‑daily oral administration may be convenient for many adults. A titration pack helps you reach maintenance gradually, which may support tolerability as guided by the label. Ongoing treatment may support stable routines when combined with regular monitoring.
Side Effects and Safety
- Headache
- High blood pressure
- Increased liver enzymes
- Diarrhea
- Back pain
- Cough
- Sinusitis or respiratory symptoms
- Swelling in hands or feet
Serious risks can include infections, bradyarrhythmia after initiation in susceptible patients, macular edema, liver injury, breathing issues, and rare posterior reversible encephalopathy syndrome. There is embryo‑fetal risk. Hypersensitivity reactions can occur. Risk of relapse increase can occur after stopping. Report vision changes, shortness of breath, signs of infection, or severe dizziness to a healthcare professional immediately. If you take insulin or sulfonylureas for diabetes, monitor for hypoglycemia per prescriber guidance when therapy changes.
Drug Interactions and Cautions
High‑level interactions include certain antiarrhythmics, QT‑prolonging drugs, some immunosuppressants, and potent CYP2C9/CYP3A inducers or inhibitors. Tell your prescriber about all medicines, including over‑the‑counter products and herbals. Avoid live attenuated vaccines during therapy and for the specified post‑treatment period. People with uncontrolled sleep apnea, severe untreated cardiac disease, or uncontrolled hypertension may need alternative options. Liver disease and eye conditions such as uveitis or diabetes require extra monitoring.
What to Expect Over Time
Relapse risk and MRI activity may decrease over time when the treatment is taken as directed. Many effects are not felt day to day, so scheduled follow‑ups, lab work, and eye checks matter. If therapy is stopped, your prescriber may suggest monitoring for worsening symptoms. Keep a simple symptom diary and bring it to visits. For related reading, see Cholesterol And Multiple Sclerosis.
Compare With Alternatives
Other approved options include S1P modulators and targeted biologics. Fingolimod is an oral S1P modulator; see Gilenya. Ofatumumab is a self‑administered anti‑CD20 therapy; see Kesimpta. Your prescriber will help choose based on disease activity, comorbidities, monitoring needs, and dosing preferences.
Pricing and Access
We offer Canadian pharmacy Mayzent price options for US adults with a valid prescription. You can review current pricing, compare supply sizes, and see estimated savings. Orders include pharmacist oversight and encrypted checkout. For education on therapies and potential savings, you can also review Neurology options and our article on Generic Alternatives.
Prefer transparent Canadian pricing with US delivery from Canada? Sign in to view available packs, add your prescription, and request a refill reminder. Looking for seasonal offers or coupon codes? Check Promotions for current notices.
Availability and Substitutions
Supply can vary by strength and pack type. If your requested pack is unavailable, your prescriber may recommend an alternative with similar clinical intent. Pharmacy teams dispense the exact product written or an approved substitution only when authorized by your prescriber and local rules.
Patient Suitability and Cost-Saving Tips
Adults with relapsing forms of MS who can complete genotype testing and monitoring may be candidates. People with contraindicated heart conditions, CYP2C9*3/*3 genotype, or pregnancy should not use this medicine. Ask about multi‑month fills to reduce refill frequency and possible dispensing fees. Set calendar reminders for doses and refills. Keep lab and eye appointments on schedule to help maintain safe access.
Questions to Ask Your Clinician
- Testing plan: what genotype and baseline checks are required?
- Start‑up plan: how long is the titration before maintenance?
- Monitoring: which labs and eye exams are needed and how often?
- Interactions: which medicines or supplements should I avoid?
- Vaccines: which immunizations are recommended before starting?
- Family planning: what contraception and washout timing apply?
- Transition: what steps are needed if switching therapies?
Authoritative Sources
Ready to proceed? Order from YouDrugstore for US delivery from Canada with prompt, express shipping and temperature-controlled handling when required. This information is not a substitute for professional medical advice; always follow your prescriber and the official label.
Express Shipping - from $25.00
Shipping with this method takes 3-5 days
Prices:
- Dry-Packed Products $25.00
- Cold-Packed Products $35.00
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $15.00
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $15.00
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Do I need genetic testing before starting this medicine?
Yes. The siponimod label requires CYP2C9 genotype testing before the first dose. People with the CYP2C9*3/*3 genotype should not take it. The result also helps determine the correct starter schedule and maintenance amount. Your healthcare professional will also check your heart rhythm history, blood pressure, eye health, and infection risk before initiation. Keep copies of your test results with your medication records for future reference.
How is the starter pack used?
Treatment begins with a short, step‑wise titration to help your body adjust. You take one tablet daily, increasing the amount according to the official guide, then continue with a once‑daily maintenance tablet. If several consecutive doses are missed early on, re‑titration may be needed. Never change your schedule without talking to your prescriber, and consult the package insert for detailed steps.
What monitoring is recommended during therapy?
Your prescriber may monitor blood pressure, liver enzymes, complete blood counts, and eye health, especially in patients with diabetes or prior uveitis. Cardiac monitoring may apply at initiation for certain heart conditions. Watch for infection symptoms and vision changes, and report new neurological issues promptly. Vaccinations with live attenuated vaccines should be avoided during treatment and for the recommended time after stopping.
Can I get vaccines while on siponimod?
Non‑live vaccines are generally permissible, but live attenuated vaccines should be avoided during treatment and for a period after the last dose. If you lack varicella‑zoster immunity, your clinician may recommend vaccination before starting. Always confirm timing with your healthcare professional, as immune responses can be reduced during therapy and schedules may need adjustment.
What side effects should I watch for early on?
Common effects include headache, elevated blood pressure, and mild liver enzyme changes. Some people notice cough or sinus symptoms. Rare but serious issues include slow heart rate after initiation in susceptible patients, macular edema with vision changes, infections, breathing difficulties, or severe neurological symptoms. Seek medical care urgently if you experience severe dizziness, chest pain, swelling, or sudden vision changes.
How should I store tablets at home and while traveling?
Keep tablets in the original blister at room temperature, away from moisture and heat. Do not store in the bathroom. When traveling, carry them in hand luggage with your prescription information and a list of your medications. Use a small weekly organizer only if kept dry. Protect from direct sunlight, and keep away from children and pets at all times.
What happens if I stop treatment suddenly?
Stopping can be associated with increased disease activity in some people. If therapy must be paused or discontinued, your prescriber may plan monitoring for worsening neurological symptoms. Never stop on your own. Discuss a taper or transition plan to another therapy, including how long to avoid live vaccines after stopping. Keep follow‑up appointments to reassess your condition and adjust the plan as needed.
